Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00229619
Status:
COMPLETED
Last Update Posted:
2018-09-18
First Post:
2005-09-29
Brief Title:
Rituximab to Treat Moderate Aplastic Anemia Pure Red Cell Aplasia or Diamond Blackfan Anemia
Sponsor:
National Heart Lung and Blood Institute NHLBI
Organization:
National Institutes of Health Clinical Center CC
Organization Data
Organization:
National Institutes of Health Clinical Center CC
Class:
NIH
Study ID:
050244
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Heart Lung and Blood Institute NHLBI
Lead Sponsor Class:
NIH
Responsible Party:
Adrian Wiestner MD
Responsible Party Title:
NHLBI Senior Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
National Heart Lung and Blood Institute NHLBI
Old Name:
None
Old Organization:
None